Overview
Overview
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The goal of pharmacovigilance is to ensure the safety and effectiveness of drugs by monitoring their use and detecting and reporting any adverse events that occur.
Good Pharmacovigilance Practices (GVP) are a set of guidelines and procedures that define the standards for pharmacovigilance activities. The GVP guidelines cover all aspects of pharmacovigilance, including pre- and post-authorization safety studies, risk management plans, signal detection, and risk communication. The guidelines are intended to ensure that all stakeholders involved in the development and use of drugs have access to accurate and reliable information about their safety and effectiveness.
Pharmacovigilance is a critical component of drug development and regulation, and it plays a vital role in ensuring that drugs are safe and effective for use by patients. The collection, analysis, and dissemination of drug safety data through pharmacovigilance activities are essential for monitoring the risks and benefits of drugs and for making informed decisions about their use.
The course provides the basics of pharmacovigilance regulations and pharmacovigilance processes, and documentation. It discusses pharmacovigilance regulatory overview and the fundamentals of AE/ADR classification, assessment, and reporting standards.
Learning Points:
Good Pharmacovigilance Practices (GVP) are a set of guidelines and procedures that define the standards for pharmacovigilance activities. The GVP guidelines cover all aspects of pharmacovigilance, including pre- and post-authorization safety studies, risk management plans, signal detection, and risk communication. The guidelines are intended to ensure that all stakeholders involved in the development and use of drugs have access to accurate and reliable information about their safety and effectiveness.
Pharmacovigilance is a critical component of drug development and regulation, and it plays a vital role in ensuring that drugs are safe and effective for use by patients. The collection, analysis, and dissemination of drug safety data through pharmacovigilance activities are essential for monitoring the risks and benefits of drugs and for making informed decisions about their use.
The course provides the basics of pharmacovigilance regulations and pharmacovigilance processes, and documentation. It discusses pharmacovigilance regulatory overview and the fundamentals of AE/ADR classification, assessment, and reporting standards.
Learning Points:
- Introduction to Drug-Related Problems
- Basic Definitions used in Pharmacovigilance
- Adverse Drug Events and Reactions (classification, assessment, reporting)
- Pharmacovigilance Processes, and Documentation
- Introduction to Pharmacovigilance Guidelines
- Individual Case Safety Reporting (ICSR)
- Career Opportunities in Pharmacovigilance
OUR STUDENTS WORK AT
NAI partners with industry-leading corporations and provides them with ready-on-day-one employees.
